Relmada Therapeutics to Participate at the Jefferies Global Healthcare Conference in London
Globe Newswire•04/11/2026•07:00 ET
0
Key Highlights
- ➤Relmada executives to participate in Jefferies Global Healthcare Conference November 16
- ➤Management will hold one-on-one investor meetings during the conference
- ➤Fireside chat scheduled for November 16 at 12:00 PM GMT/7 AM ET
- ➤Lead candidates NDV-01 and sepranolone advancing through clinical development
CORAL GABLES, Fla., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology and central nervous system disorders, today announced that Sergio Traversa, Chief Executive Officer, and Maged Shenouda, Chief Financial Officer, will participate in the Jefferies Global Healthcare Conference being held in London, UK, from November 16 - 19, 2026.
Jefferies Global Healthcare Conference in London Format: Fireside Chat Date: Monday, November 16, 2026 Time: 12:00 PM GMT/7 AM ET Webcast: Click Here
Get started
Create a free account to read the full story.